Yun, KL, Miller, DC, Moore, KA, et al. Durability of the Hancock MO bioprosthesis compared with standard aortic valve bioprostheses. Ann Thorac Surg 1995;60(2 Suppl):S221–8.Google Scholar

Jamieson, WR, Janusz, MT, Miyagishima, RT, et al. The Carpentier–Edwards standard porcine bioprosthesis: Long-term evaluation of the high pressure glutaraldehyde fixed prosthesis. J Card Surg 1988;3(3 Suppl):321–36.Google Scholar

Badduke, BR, Jamieson, WR, Miyagishima, RT, et al. Pregnancy and childbearing in a population with biologic valvular prostheses. J Thorac Cardiovasc Surg 1991;102:179–86.CrossRefGoogle Scholar

Avila, WS, Rossi, EG, Grinberg, M, et al. Influence of pregnancy after bioprosthetic valve replacement in young women: A prospective five year study. J Heart Valve Dis 2002;11:864–9.Google ScholarPubMed

Jamieson, WR, Miller, DC, Akins, CW, et al. Pregnancy and bioprostheses: Influence on structural valve deterioration. Ann Thorac Surg 1995;60 (2 Suppl):S282–6; discussion S287.Google Scholar

North, RA, Sadler, L, Stewart, AW, et al. Long term survival and valve related complications in young women with cardiac valve replacements. Circulation 1999;99:2669–76.CrossRefGoogle ScholarPubMed

McClintock, C. Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: No easy option. Thromb Res 2011;127 (Suppl 3):S56–60.CrossRefGoogle Scholar

Elkayam, U, Singh, H, Irani, A, et al. Anticoagulation in pregnant women with prosthetic heart valves. J Cardiovasc Pharmacol Ther 2004;9:107–15.Google Scholar

Dahlman, TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993;168:1265–70.CrossRefGoogle ScholarPubMed

Decousus, HA, Croze, M, Levi, FA, et al. Circadian changes in anticoagulant effect of heparin infused at a constant rate. Br Med J (Clin Res Ed) 1985;290:341–4.Google Scholar

Chunilal, SD, Young, E, Johnston, MA, et al. The APTT response of pregnant plasma to unfractionated heparin. Thromb Haemost 2002;87:92–7.Google Scholar

Brill-Edwards, PA, Demers, C, Donovan, D, et al. Establishing a therapeutic range for heparin therapy. Chest 1993;104:1679–84.Google Scholar

Nishimura, RA, Otto, CM, Bonow, RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2438–88.Google Scholar

European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.Google Scholar

Chan, WS, Anand, S, Ginsberg, JS. Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature. Arch Intern Med 2000;160:191–6.Google Scholar

Meschengieser, SS, Fondevila, CG, Santarelli, MT, et al. Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart 1999;82:23–6.Google Scholar

Hall, JG, Pauli, RM, Wilson, KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980;68:122–40.Google Scholar

Ginsberg, JS, Hirsh, J, Turner, DC, et al. Risks to the fetus of anticoagulant therapy during pregnancy. Thromb Haemost 1989;61:197–203.Google Scholar

Hung, L, Rahimtoola, SH. Prosthetic valves and pregnancy. Circulation 2003;107:1420–6.Google Scholar

Cotrufo, M, de Luca, TS, Calabro, R, et al. Coumarin anticoagulation during pregnancy in patients with mechanical valve prostheses. Eur J Cardiothorac Surg 1991;5:300–4; discussion 305.Google Scholar

Vitale, N, De Feo, M, De Santo, LS, et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637–41.Google Scholar

Mazibuko, B, Ramnarain, H, Moodley, J. An audit of pregnant women with prosthetic heart valves at a tertiary hospital in South Africa: A five-year experience. Cardiovasc J Afr 2012;23:216–21.Google Scholar

Sillesen, M, Hjortdal, V, Vejlstrup, N, et al. Pregnancy with prosthetic heart valves—30 years’ nationwide experience in Denmark. Eur J Cardiothorac Surg 2011;40:448–54.Google Scholar

Wesseling, J, Van Driel, D, Heymans, HS, et al. Coumarins during pregnancy: Long-term effects on growth and development of school-age children. Thromb Haemost 2001;85:609–13.Google Scholar

McClintock, C. Anticoagulant choices in pregnant women with mechanical heart valves: Balancing maternal and fetal risks—the difference the dose makes. Thromb Res 2013;131 (Suppl 1):S8–10.CrossRefGoogle Scholar

Soma-Pillay, P, Nene, Z, Mathiva, TM, et al. The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valves. Obstset Medicine 2011;4:24–27.Google Scholar

Basude, S, Hein, C, Curtis, SL, et al. Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: What are the risks? A retrospective observational study. BJOG 2012;119:1008–13; discussion 12–13.CrossRefGoogle ScholarPubMed

Thorp, JA, Poskin, MF, McKenzie, DR, et al. Perinatal factors predicting severe intracranial hemorrhage. Am J Perinatol 1997;14:631–6.Google Scholar

White, RH, Ginsberg, JS. Low-molecular-weight heparins: Are they all the same? Br J Haematol 2003;121:12–20.CrossRefGoogle ScholarPubMed

Rowan, JA, McCowan, LM, Raudkivi, PJ, et al. Enoxaparin treatment in women with mechanical heart valves during pregnancy. Am J Obstet Gynecol 2001;185:633–7.Google Scholar

McClintock, C, McCowan, LM, North, RA. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. BJOG 2009;116:1585–92.CrossRefGoogle Scholar

Abildgaard, U, Sandset, PM, Hammerstrom, J, et al. Management of pregnant women with mechanical heart valve prosthesis: Thromboprophylaxis with low molecular weight heparin. Thromb Res 2009;124:262–7.Google Scholar

Mahesh, B, Evans, S, Bryan, AJ. Failure of low molecular-weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: Case report and a review of options for anticoagulation. J Heart Valve Dis 2002;11:745–50.Google Scholar

Yinon, Y, Siu, SC, Warshafsky, C, et al. Use of low molecular weight heparin in pregnant women with mechanical heart valves. Am J Cardiol 2009;104:1259–63.Google Scholar

Oran, B, Lee-Parritz, A, Ansell, J. Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost 2004;92:747–51.Google Scholar

Saeed, CR, Frank, JB, Pravin, M, et al. A prospective trial showing the safety of adjusted-dose enoxaparin for thromboprophylaxis of pregnant women with mechanical prosthetic heart valves. Clin Appl Thromb Hemost 2011;17:313–19.Google ScholarPubMed

Quinn, J, Von Klemperer, K, Brooks, R, et al. Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: A single-center experience. Haematologica 2009;94:1608–12.Google Scholar

Sephton, V, Farquharson, RG, Topping, J, et al. A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy. Obstet Gynecol 2003;101:1307–11.Google Scholar

Casele, HL, Laifer, SA, Woelkers, DA, et al. Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol 1999;181(5 Pt 1):1113–17.Google Scholar

Barbour, LA, Oja, JL, Schultz, LK. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol 2004;191:1024–9.Google Scholar

Ginsberg, JS, Chan, WS, Bates, SM, et al. Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 2003;163:694–8.Google Scholar

Cappelleri, JC, Fiore, LD, Brophy, MT, et al. Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: A meta analysis. Am Heart J 1995;130 (3 Pt 1):547–52.CrossRefGoogle Scholar

Imperiale, TF, Petrulis, AS. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991;266:260–4.Google Scholar

Huisman, CM, Zwart, JJ, Roos-Hesselink, JW et al. Incidence and predictors of maternal cardiovascular mortality and severe morbidity in the Netherlands: A prospective cohort study. PLoS ONE 2013;8:e56494.Google Scholar

Cantwell, R, Clutton-Brock, T, Cooper, G. Saving Mothers’ Lives. Reviewing maternal death to make motherhood safer 2006–2008. BJOG 2011;118(Supp.1):1–203.Google Scholar

Mabie, WC, DiSessa, TG, Crocker, LG, et al. A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol 1994;170:849–56.Google Scholar

Robson, SC, Hunter, S, Boys, RJ. et al. Serial study of factors influencing changes in cardiac output during pregnancy. Am J Physiol 1989;256:H1060–5.Google Scholar

Poppas, A, Shroff, SG, Korcarz, CE et al. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation 1997;95:2407–15.Google Scholar

Gutin, LS, Merz, AE, Bakalov, VK et al. Parity and aortic dimensions in healthy women. Int J Cardiol 2013;165(2):383–4.Google Scholar

Campisi, D, Cutolo, M, Carruba, G et al. Evidence for soluble and nuclear site I binding of estrogens in human aorta. Atherosclerosis 1993;103:267–77.Google Scholar

Wingrove, CS, Garr, E, Godsland, IF et al. 17-beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim Biophys Acta 1998;1406:169–74.Google Scholar

Manallo-Estrella, P, Barker, AE. Histopathologic findings in human aortic media associated with pregnancy. Arch Path 1967;83:336–41.Google Scholar

Pedowitz, P, Perell, A. Aneurysms complicated by pregnancy. I. Aneurysms of the aorta and its major branches. Am J Obstet Gynecol 1957;73(4):720–35.Google Scholar

Pyeritz, RE. Disorders of fibrillins and microfibrilogenesis: Marfan syndrome, MASS phenotype, contractural arachnodactyly and related conditions. In: Principles and Practice of Medical Genetics, 3rd edn. New York: Churchill Livingstone; 1996.Google Scholar

Lind, J, Wallenburg, HC. The Marfan syndrome and pregnancy: A retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol 2001;98(1):28–35.Google Scholar

Meijboom, LJ, Drenthen, W, Pieper, PG et al. Obstetric complications in Marfan syndrome. Int J Cardiol 2006;110:53–9.CrossRefGoogle ScholarPubMed

Pini, R, Roman, MJ, Kramer-Fox, R et al. Mitral valve dimensions and motion in Marfan patients with and without mitral valve prolapse. Comparison to primary mitral valve prolapse and normal subjects. Circulation 1989;80:915–24.Google Scholar

Schnitker, MA, Bayer, CA. Dissection aneurysm of the aorta in young individuals, particularly in association with pregnancy. Ann Intern Med 1944;29:486–511.Google Scholar

Williams, GM, Gott, VL, Brawley, RK. et al. Aortic disease associated with pregnancy. J Vasc Surg 1988;8:470–5.Google Scholar

Hirst, AE, Johns, VJ, Kime, SW. Dissecting aneurysm of the aorta: A review of 505 cases. Medicine (Baltimore) 1958;37:217–79.Google Scholar

Oskoui, R, Lindsay, J. Aortic dissection in women < 40 years of age and the unimportance of pregnancy. Am J Cardiol 1994;73(11):821–3.Google Scholar

Meijboom, LJ, Vos, FE, Timmermans, J et al. Pregnancy and aortic root growth in the Marfan syndrome: A prospective study. Eur Heart J 2005:26(9):914–20.CrossRefGoogle ScholarPubMed

European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.Google Scholar

Hiratzka, LF, Bakris, GL, Beckman, JA et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J Am Coll Cardiol 2010;55(14):e27–e129.Google Scholar

Groenink, M, Lohuis, TAJ, Tijssen, JGP et al. Survival and complication free survival in Marfan syndrome: Implications of current guidelines. Heart 1999;82:499–504.CrossRefGoogle ScholarPubMed

Silverman, DI, Gray, J, Roman, MJ et al. Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival. J Am Coll Cardiol 1995;26(4):1062–7.Google Scholar

Immer, FF, Bansi, AG, Immer-Bansi, AS. et al. Aortic dissection in pregnancy: Analysis of risk factors and outcome. Ann Thorac Surg 2003;76(1):309–14.Google Scholar

Williams, A, Child, A, Rowntree, J et al. Marfan syndrome: Successful pregnancy after aortic root and arch replacement. BJOG 2002;109(10):1187–8.Google Scholar

Shores, J, Berger, KR, Murphy, EA et al. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan syndrome. N Engl J Med 1994;330(19):1335–41.Google Scholar

Groenink, M, de Roos, A, Mulder, BJ et al.Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol 1998;82(2):203–8.Google Scholar

Gao, L, Mao, Q, Wen, D et al. The effect of beta-blocker therapy on progressive aortic dilatation in children and adolescents with Marfan syndrome: A meta-analysis. Acta Paediatr 2011;100(9):e101–5.Google Scholar

Groenink, M, den Hartog, AW, Franken, R et al. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: A randomized controlled trial. Eur Heart J 2013;34(45):3491–500.CrossRefGoogle ScholarPubMed

Harton, GL, Tsipouras, P, Sisson, ME. et al. Preimplantation genetic testing for Marfan syndrome. Mol Hum Reprod 1996;2(9):713–5.Google Scholar

Regalado, ES, Guo, DC, Estrera, AL et al. Acute aortic dissections with pregnancy in women with ACTA2 mutations. Am J Med Genet A 2014;164:106–12.CrossRefGoogle Scholar

Rossiter, JP, Repke, JT, Morales, AJ et al. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol 1995;173(5):1599–606.CrossRefGoogle ScholarPubMed

Zeebregts, CJ, Schepens, MA, Hameeteman, TM et al. Acute aortic dissection complicating pregnancy. Ann Thorac Surg 1997;64:1345–8.Google Scholar

Parry, AJ, Westaby, S. Cardiopulmonary bypass during pregnancy. Ann Thorac Surg 1996;61(6):1865–9.Google Scholar

Mahli, A, Izdes, S, Coskun, D. Cardiac operations during pregnancy: Review of factors influencing fetal outcome. Ann Thorac Surg 2000;69:1622–6.CrossRefGoogle ScholarPubMed

Lacassie, HJ, Millar, S, Leithe, LG et al. Dural ectasia: A likely cause of inadequate spinal anaesthesia in two parturients with Marfan syndrome. Br J Anaesth 2005;94(4):500–4.Google Scholar

Beauchesne, LM, Connolly, HM, Ammash, NM et al. Coarctation of the aorta: Outcome of pregnancy. J Am Coll Cardiol 2001;38(6):1728–33.CrossRefGoogle ScholarPubMed

Stern, HC, Locher, D, Wallnofer, K et al. Noninvasive assessment of coarctation of the aorta: Comparative measurements by two-dimensional echocardiography, magnetic resonance, and angiography. Pediatr Cardiol 1991;12(1):1–5.Google Scholar

Stewart, AB, Ahmed, R, Travill, CM et al. Coarctation of the aorta life and health 20–44 years after surgical repair. Br Heart J 1993;69(1):65–70.CrossRefGoogle ScholarPubMed

Siu, SC, Sermer, M, Colman, JM et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104(5):515–21.Google Scholar

Kupferminc, MJ, Lessing, JB, Jaffa, A et al. Fetomaternal blood flow measurements and management of combined coarctation and aneurysm of the thoracic aorta in pregnancy. Acta Obstet Gynecol Scand 1993;72(5):398–402.Google Scholar

Knyshov, GV, Sitar, LL, Glagola, MD et al. Aortic aneurysms at the site of the repair of coarctation of the aorta: A review of 48 patients. Ann Thorac Surg 1996;61(3):935–9.Google Scholar

Rose, V, Gold, RJM, Lindsay, G et al. A possible increase in the incidence of congenital heart defects among the offspring of affected parents. JACC 1985;6:376–82.Google Scholar

Cecconi, M, Manfrin, M, Moraca, A et al. Aortic dimensions in patients with bicuspid aortic valve without significant valve dysfunction. Am J Cardiol 2005;95(2):292–4.Google Scholar

Oliver, JM, Alonso-Gonzalez, R, Gonzalez, AE et al. Risk of aortic root or ascending aorta complications in patients with bicuspid aortic valve with and without coarctation of the aorta. Am J Cardiol 2009;104(7):1001–6.Google Scholar

McKellar, SH, MacDonald, RJ, Michelena, HI et al. Frequency of cardiovascular events in women with a congenitally bicuspid aortic valve in a single community and effect of pregnancy on events. Am J Cardiol 2011;107:96–9.Google Scholar

Ostberg, JE, Brookes, JA, McCarthy, C et al. A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J Clin Endocrinol Metab 2004;89(12):5966–71.Google Scholar

Hagman, A, Loft, A, Wennerholm, UB et al. Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: A Nordic cohort study. Hum Reprod 2013;28(6):1598–609.Google Scholar

Lurie, S, Manor, M, Hagay, ZJ. The threat of type IV Ehlers-Danlos syndrome on maternal well-being during pregnancy: Early delivery may make the difference. J Obstet Gynaecol 1998;18(3):245–8.Google Scholar

Hauenstein, E, Frank, H, Bauer, JS. et al. Takayasu’s arteritis in pregnancy: Review of literature and discussion. J Perinat Med 2010;38:55–62.Google Scholar

Haththotuwa, HR, Attygalle, D, Jayatilleka, AC, et al. Maternal mortality due to cardiac disease in Sri Lanka. Int J Gynecol Obstet 2009;104 :194–8.Google Scholar

Naidoo, DP, Desai, DK, Moodley, J. Maternal deaths due to pre-existing cardiac disease. Cardiovasc J South Afr 2002;13 :17–20.Google Scholar

Lewis, G, ed. Why Mothers Die 2000–2002: The Sixth Report of Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press; 2004.Google Scholar

Silversides, CK, Colman, JM, Sermer, M, et al. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol 2003;91:1382–5.Google Scholar

European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.Google Scholar

Nercolini, DC, da Rocha Loures Bueno, R, Eduardo Guerios, E, et al. Percutaneous mitral balloon valvuloplasty in pregnant women with mitral stenosis. Catheter Cardiovasc Interv 2002;57:318–22.Google Scholar

Routray, SN, Mishra, TK, Swain, S, et al. Balloon mitral valvuloplasty during pregnancy. Int J Gynaecol Obstet 2004;85:18–23.Google Scholar

Gupta, A, Lokhandwala, YY, Satoskar, PR, et al. Balloon mitral valvotomy in pregnancy: Maternal and fetal outcomes. J Am Coll Cardiol 1998;187:409–15.Google Scholar

Sivadasanpillai, H, Srinivasan, A, Sivasubramoniam, S, et al. Long term outcome of patients undergoing balloon mitral valvotomy in pregnancy. Am J Cardiol 2005;95:1504–6.Google Scholar

Aggarwal, N, Suri, V, Goyal, A, et al. Closed mitral valvotomy in pregnancy and labour. Int J Gynecol Obstet;2005:118–21.Google Scholar

Hameed, A, Karaalp, IS, Tummala, PP, et al. The effects of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001;37:893–9.Google Scholar

Aria, F, Pineda, J. Aortic stenosis and pregnancy. J Reprod Med 1978;20:229–32.Google Scholar

Silversides, C, Colman, J, Sermer, M, et al. Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol 2003;91:1386–9.Google Scholar

Tzemos, N, Silversides, CK, Colman, JM, et al. Late cardiac outcomes after pregnancy in women with congenital aortic stenosis. Am Heart J 2009;157 :474–80.Google Scholar

Magne, J, Lancellotti, P, Pierard, LA. Exercise testing in asymptomatic severe aortic stenosis. J Am Coll Cardol Cardiovasc Imaging 2014;7 (2):188–99.Google Scholar

Radford, D, Walters, DL. Balloon aortic valvotomy in pregnancy. Aust N Z J Obstet Gynaecol 2004;44:577–9.Google Scholar

Gopal, K, Hudson, IM, Ludmir, J, et al. Homograft aortic root replacement during pregnancy. Ann Thorac Surg 2002;74:243–5.Google Scholar

Parry, AJ, Westaby, S. Cardiopulmonary bypass during pregnancy. Ann Thorac Surg 1996;61:1865–9.Google Scholar

Chambers, CE, Clark, SL. Cardiac surgery during pregnancy. Clin Obstet Gynecol 1994;37:316–23.Google Scholar

Jahangiri, M, Clarke, J, Prefumo, F, et al. Cardiac surgery during pregnancy: Pulsatile or non-pulsatile perfusion? J Thorac Cardiovasc Surg 2003;126:894–5.Google Scholar

Ioscovich, AM, Goldszmidt, E, Fadeev, AV, et al. Peripartum anesthetic management of patients with aortic valve stenosis: A retrospective study and literature review. Int J Obstst Anesth 2009;18:379–86.Google Scholar

Suntharalingam, G, Dob, D, Yentis, SM. Obstetric epidural analgesia in aortic stenosis: A low-dose technique for labour and instrumental delivery. Int J Obstet Anesth 2001;10:129–34.Google Scholar

Nieminen, HP, Jokinen, EV, Sairanen, HI. Late results of pediatric cardiac surgery in Finland: A population-based study with 96% follow-up. Circulation 2001;104:570–5.Google Scholar

Thorne, S, Deanfield, J. Long-term outlook in treated congenital heart disease. Arch Dis Child 1996;75:6–8.CrossRefGoogle ScholarPubMed

Wren, C, O’Sullivan, JJ. Survival with congenital heart disease and need for follow up in adult life. Heart 2001;85:438–43.Google Scholar

Hoffman, JIE. Incidence, mortality, and natural history. In: Anderson, RA et al., eds. Paediatric Cardiology. London: Churchill Livingstone; 2002. pp. 111–139.Google Scholar

Uebing, A, Steer, PJ, Yentis, SM, et al. Pregnancy and congenital heart disease. BMJ 2006;332:401–6.Google Scholar

Warnes, CA, Williams, RG, Bashore, TM, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118:e714–833.Google Scholar

European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.Google Scholar

Siu, SC, Sermer, M, Colman, JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515–21.Google Scholar

Siu, SC, Sermer, M, Harrison, DA, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997;96:2789–94.Google Scholar

Franklin, WJ, Gandhi, M. Congenital heart disease in pregnancy. Cardiol Clin 2012;30:383–94.Google Scholar

Steer, PJ. Pregnancy and contraception. In: Gatzoulis, MA, et al., eds. Adult Congenital Heart Disease: A Practical Guide. Malden, MA: BMJ Publishing Group; 2005. pp. 16–35.Google Scholar

Baddour, LM, Wilson, WR, Bayer, AS, et al. Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394–434.Google Scholar

Feldt, RH, Avasthey, P, Yoshimasu, F, et al. Incidence of congenital heart disease in children born to residents of Olmsted County, Minnesota, 1950–1969. Mayo Clin Proc 1971;46:794–9.Google Scholar

Brochu, M-C, Baril, J-F, Dore, A, et al. Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation 2002;106:1821–6.Google Scholar

Attie, F, Rosas, M, Granados, N, et al. Surgical treatment for secundum atrial septal defects in patients >40 years old. A randomized clinical trial. J Am Coll Cardiol 2001;38:2035–42.Google Scholar

Gatzoulis, MA, Freeman, MA, Siu, SC, et al. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med 1999;340:839–46.Google Scholar

Murphy, JG, Gersh, BJ, McGoon, MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 1990;323:1645–50.Google Scholar

Yap, S-C, Drenthen, W, Meijboom, FJ, et al. Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial septal defect. BJOG 2009;116:1593–601.Google Scholar

Giglia, TM, Massicotte, MP, Tweddell, JS, et al. Prevention and treatment of thrombosis in pediatric and congenital heart disease: A scientific statement from the American Heart Association. Circulation 2013;128:2622–703.Google Scholar

Babu-Narayan, S, Gatzoulis, MA. Tetralogy of Fallot. In: Gatzoulis, M, Wegg, GD, Daubeney, PEF, eds. Diagnosis and management of adult congenital heart disease, 2nd edn. Philadelphia, PA: Elsevier Saunders; 2011. pp. 316–27.Google Scholar

Hoffman, JI. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol 1995;16:103–13.Google Scholar

Gatzoulis, MA, Balaji, S, Webber, SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: A multicentre study. Lancet 2000;356:975–81.Google Scholar

Khairy, P, Ouyang, DW, Fernandes, SM, et al. Pregnancy outcomes in women with congenital heart disease. Circulation 2006;113:517–24.Google Scholar

Greutmann, M, Von Klemperer, K, Brooks, R, et al. Pregnancy outcome in women with congenital heart disease and residual haemodynamic lesions of the right ventricular outflow tract. Eur Heart J 2010;31:1764–70.Google Scholar

Veldtman, GR, Connolly, HM, Grogan, M, et al. Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol 2004;44:174–80.Google Scholar

Meijer, JM, Pieper, PG, Drenthen, W, et al. Pregnancy, fertility, and recurrence risk in corrected tetralogy of Fallot. Heart 2005;91:801–5.Google Scholar

Balci, A, Drenthen, W, Mulder, BJM, et al. Pregnancy in women with corrected tetralogy of Fallot: Occurrence and predictors of adverse events. Am Heart J 2011;161:307–13.Google Scholar

Kamiya, CA, Iwamiya, T, Neki, R, et al. Outcome of pregnancy and effects on the right heart in women with repaired tetralogy of fallot. Circ J 2012;76:957–63.Google Scholar

Uebing, A, Arvanitis, P, Li, W, et al. Effect of pregnancy on clinical status and ventricular function in women with heart disease. Int J Cardiol 2010;139:50–9.Google Scholar

Nora, JJ. From generational studies to a multilevel genetic-environmental interaction. J Am Coll Cardiol 1994;23:1468–71.Google Scholar

Gelson, E, Gatzoulis, M, Steer, PJ, et al. Tetralogy of Fallot: Maternal and neonatal outcomes. BJOG 2008;115:398–402.Google Scholar

Connolly, HM, Warnes, CA. Ebstein’s anomaly: Outcome of pregnancy. J Am Coll Cardiol 1994;23:1194–8.Google Scholar

Katsuragi, S, Kamiya, C, Yamanaka, K, et al. Risk factors for maternal and fetal outcome in pregnancy complicated by Ebstein anomaly. Am J Obstet Gynecol 2013;209:452.e1–6.Google Scholar

Brickner, ME, Hillis, LD, Lange, RA. Congenital heart disease in adults. First of two parts. N Engl J Med 2000;342:256–63.Google Scholar

Elkayam, U, Bitar, F. Valvular heart disease and pregnancy part I: Native valves. J Am Coll Cardiol 2005;46:223–30.Google Scholar

Loya, YS, Desai, DM, Sharma, S. Mitral and pulmonary balloon valvotomy in pregnant patients. Indian Heart J 1993;45:57–9.Google Scholar

Connolly, HM, Grogan, M, Warnes, CA. Pregnancy among women with congenitally corrected transposition of great arteries. J Am Coll Cardiol 1999;33:1692–5.Google Scholar

Therrien, J, Barnes, I, Somerville, J. Outcome of pregnancy in patients with congenitally corrected transposition of the great arteries. Am J Cardiol 1999;84:820–4.Google Scholar

Bowater, SE, Selman, TJ, Hudsmith, LE, et al. Long-term outcome following pregnancy in women with a systemic right ventricle: Is the deterioration due to pregnancy or a consequence of time? Congenit Heart Dis 2013;8:302–7.Google Scholar

Kowalik, E, Klisiewicz, A, Biernacka, EK, et al. Pregnancy and long-term cardiovascular outcomes in women with congenitally corrected transposition of the great arteries. Int J Gynaecol Obstet 2014;125:154–7.Google Scholar

Dob, DP, Naguib, MA, Gatzoulis, MA. A functional understanding of moderate to complex congenital heart disease and the impact of pregnancy. Part I: The transposition complexes. Int J Obstet Anesth 2010;19:298–305.Google Scholar

Clarkson, PM, Wilson, NJ, Neutze, JM, et al. Outcome of pregnancy after the Mustard operation for transposition of the great arteries with intact ventricular septum. J Am Coll Cardiol 1994;24:190–3.Google Scholar

Drenthen, W, Pieper, PG, Roos-Hesselink, JW, et al. Outcome of pregnancy in women with congenital heart disease: A literature review. J Am Coll Cardiol 2007;49:2303–11.Google Scholar

Guédès, A, Mercier, L-A, Leduc, L, et al. Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries. J Am Coll Cardiol 2004;44:433–7.Google Scholar

Canobbio, MM, Mair, DD, van der Velde, M, et al. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996;28:763–7.Google Scholar

Ono, M, Boethig, D, Goerler, H, et al. Clinical outcome of patients 20 years after Fontan operation–effect of fenestration on late morbidity. Eur J Cardiothorac Surg 2006;30:923–9. doi:10.1016/j.ejcts.2006.08.025.Google Scholar

D’ Udekem, Y, Iyengar, AJ, Cochrane, AD, et al. The Fontan procedure: Contemporary techniques have improved long-term outcomes. Circulation 2007;116:I157–64.Google Scholar

Nitsche, JF, Phillips, SD, Rose, CH, et al. Pregnancy and delivery in patients with fontan circulation: A case report and review of obstetric management. Obstet Gynecol Surv 2009;64:607–14.CrossRefGoogle ScholarPubMed

Neumayer, U, Somerville, J. Outcome of pregnancies in patients with complex pulmonary atresia. Heart 1997;78:16–21.Google Scholar

Presbitero, P, Somerville, J, Stone, S, et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 1994;89:2673–6.Google Scholar

Gatzoulis, MA, Swan, L, Therrien, J, et al. Adult Congenital Heart Disease: A Practical Guide. Oxford: BMJ Publishing Group, 2005.Google Scholar

Uebing, A, John, A, Gatzoulis, M. Adult congenital heart disease. In: Myerson, SG, et al. Emergencies in Cardiology. New York: Oxford University Press; 2009. pp. 217–46.Google Scholar

Simonneau, G, Gatzoulis, MA, Adatia, I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D34–41.CrossRefGoogle ScholarPubMed

Kiely, DG, Elliot, CA, Sabroe, I, Condliffe, R. Pulmonary hypertension: Diagnosis and management. BMJ. 2013;346:f2028.Google Scholar

Condliffe, R, Kiely, DG, Gibbs, JS, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008;177:1122–7.Google Scholar

Humbert, M, Sitbon, O, Simonneau, G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351:1425–36.Google Scholar

Humbert, M, Morrell, NW, Archer, SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:13S–24S.Google Scholar

Moser, KM, Bloor, CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993;103:685–92.Google Scholar

Montani, D, Achouh, L, Dorfmuller, P, et al. Pulmonary veno-occlusive disease: Clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore). 2008;87:220–33.Google Scholar

Rich, S, Dantzker, DR, Ayres, SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987;107:216–23.Google Scholar

Swift, AJ, Rajaram, S, Condliffe, R, et al. CT features of pulmonary arterial hypertension and its major subtypes: A systematic CT evaluation of 292 patients from the ASPIRE registry. Thorax. 2015;70:382–7.Google Scholar

Swift, AJ, Rajaram, S, Condliffe, R, et al. Normalised cardiovascular magnetic resonance volumetric measurements have prognostic value in idiopathic pulmonary arterial hypertension. Circ Cardiovasc Imaging. 2013;10:1036–47.Google Scholar

Swift, AJ, Rajaram, S, Condliffe, R, et al. Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry. J Cardiovasc Magn Reson. 2012;14:40.Google Scholar

Swift, AJ, Wild, JM, Nagle, SK, et al. Quantitative magnetic resonance imaging of pulmonary hypertension: A practical approach to the current state of the art. J Thorac Imaging. 2014;29:68–79.Google Scholar

Ling, Y, Johnson, MK, Kiely, DG, et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland. Am J Respir Crit Care Med. 2012;186:790–6.Google Scholar

Stupi, AM, Steen, VD, Owens, GR, et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum. 1986;29:515–24.Google Scholar

Rubin, LJ, Mendoza, J, Hood, M, et al. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial. Ann Intern Med. 1990;112:485–91.Google Scholar

Rubin, LJ, Badesch, DB, Barst, RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med. 2002;346:896–903.Google Scholar

Pulido, T, Adzerikho, I, Channick, RN, et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med. 2013;369:809–18.Google Scholar

Galie, N, Olschewski, H, Oudiz, RJ, et al. Ambrisentan for the treatment of pulmonary arterial hypertension: Results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation. 2008;117:3010–19.Google Scholar

Galie, N, Ghofrani, HA, Torbicki, A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353:2148–57.Google Scholar

Galie, N, Brundage, BH, Ghofrani, HA, et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation. 2009;119:2894–903.Google Scholar

Ghofrani, HA, Galie, N, Grimminger, F, et al. Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med. 2013;369:330–40.Google Scholar

Olschewski, H, Simonneau, G, Galie, N, et al. Aerosolized Iloprost Randomized Study G. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002;347:322–9.Google Scholar

Simonneau, G, Barst, RJ, Galie, N, et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2002;165:800–4.Google Scholar

Higenbottam, TW, Butt, AY, Dinh-Xaun, AT, et al. Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost. Heart. 1998;79:175–9.Google Scholar

Benza, RL, Tapson, VF, Gomberg-Maitland, M, et al. One-year experience with intravenous treprostinil for pulmonary arterial hypertension. J Heart Lung Transplant. 2013;32:889–96.Google Scholar

Weiss, BM, Zemp, L, Seifert, B, et al. Outcome of pulmonary vascular disease in pregnancy: A systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998;31:1650–7.Google Scholar

Weiss, BM, Hess, OM. Pulmonary vascular disease and pregnancy: Current controversies, management strategies, and perspectives. Eur Heart J. 2000;21:104–15.CrossRefGoogle Scholar

Poppas, A, Shroff, SG, Korcarz, CE, et al. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation. 1997;95:2407–15.Google Scholar

Hunter, S, Robson, SC. Adaptation of the maternal heart in pregnancy. British Heart Journal. 1992;68:540–3.Google Scholar

Cheek, TG, Gruttsche, BB. Maternal physiologic alteration during pregnancy. In: Shnider and Levinson’s Anesthesia for Obstetrics. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 3–18.Google Scholar

Bonnin, M, Mercier, FJ, Sitbon, O, et al. Severe pulmonary hypertension during pregnancy: Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology. 2005;102:1133–7; discussion 1135A–1136A.Google Scholar

Easterling, TR, Ralph, DD, Schmucker, BC. Pulmonary hypertension in pregnancy: Treatment with pulmonary vasodilators. Obstet Gynecol. 1999;93:494–8.Google Scholar

Gleicher, N, Midwall, J, Hochberger, D, Jaffin, H. Eisenmenger’s syndrome and pregnancy. Obstet Gynecol Surv. 1979;34:721–41.Google Scholar

Avila, WS, Grinberg, M, Snitcowsky, R, et al. Maternal and fetal outcome in pregnant women with Eisenmenger’s syndrome. Eur Heart J. 1995;16:460–4.Google Scholar

Presbitero, P, Rabajoli, F, Somerville, J. Pregnancy in patients with congenital heart disease. Schweiz Med Wochenschr. 1995;125:311–15.Google Scholar

Presbitero, P, Somerville, J, Stone, S, et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation. 1994;89:2673–6.Google Scholar

Saha, A, Balakrishnan, KG, Jaiswal, PK, et al. Prognosis for patients with Eisenmenger syndrome of various etiology. Int J Cardiol. 1994;45:199–207.Google Scholar

Smedstad, KG, Cramb, R, Morison, DH. Pulmonary hypertension and pregnancy: A series of eight cases. Can J Anaesth. 1994;41:502–12.Google Scholar

Bedard, E, Dimopoulos, K, Gatzoulis, MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J. 2009;30:256–65.Google Scholar

Elliot, CA, Stewart, P, Webster, VJ, et al. The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension. Eur Respir J. 2005;26:168–73.Google Scholar

Monnery, L, Nanson, J, Charlton, G. Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. Br J Anaesth. 2001;87:295–8.Google Scholar

Bendayan, D, Hod, M, Oron, G, et al. Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy. Obstet Gynecol. 2005;106:1206–10.Google Scholar

Ma, L, Liu, W, Huang, Y. Perioperative management for parturients with pulmonary hypertension: Experience with 30 consecutive cases. Frontiers of Medicine. 2012;6:307–10.Google Scholar

Duarte, AG, Thomas, S, Safdar, Z, et al. Management of pulmonary arterial hypertension during pregnancy: A retrospective, multicenter experience. Chest. 2013;143:1330–6.Google Scholar

Cotrim, SC, Loureiro, MJ, Avillez, T, et al. Three cases of pregnancy in patients with severe pulmonary arterial hypertension: Experience of a single unit. Rev Port Cardiol. 2010;29:95–103.Google Scholar

Kiely, DG, Condliffe, R, Webster, V, et al. Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach. BJOG. 2010;117:565–74.Google Scholar

Rosengarten, D, Blieden, LC, Kramer, MR. Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J 2012;40:1304–5.Google Scholar

Curry, RA, Fletcher, C, Gelson, E, et al. Pulmonary hypertension and pregnancy–a review of 12 pregnancies in nine women. BJOG. 2012;119:752–61.Google Scholar

Jais, X, Olsson, KM, Barbera, JA, et al. Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J 2012;40:881–5.Google Scholar

Kiely, DG, Condliffe, R, Wilson, V, et al. Pregnancy and pulmonary hypertension: A practical approach to management. Obstetric Medicine. 2013;6:144–54.Google Scholar

Actelion Pharmaceuticals (Data on file). 3rd Trax PMS Data Report to CPMP for the period 24 May to 19 February 2003. 2003.Google Scholar

Billings, C, Waterhouse, J, Armstrong, IJ, et al. The incremental shuttle walking test safely assesses exercise capacity in pulmonary hypertension. Eur Respir J. 2004;24:S(137).Google Scholar

Elliot, CA, Armstrong, IJ, Billings, C, et al. Incremental shuttle walking test distance predicts poor prognosis in pulmonary hypertension. Eur Respir J. 2004;24:S138.Google Scholar

Huddy, CL, Johnson, A, Hope, PL. Educational and behavioural problems in babies of 32–35 weeks gestation. Arch Dis Child Fetal Neonatal Ed. 2001;85:F23–8.Google Scholar

Jonas, MM, Tanser, SJ. Lithium dilution measurement of cardiac output and arterial pulse waveform analysis: An indicator dilution calibrated beat-by-beat system for continuous estimation of cardiac output. Curr Opin Crit Care. 2002;8:257–61.Google Scholar

Hema, KR, Johanson, R. Techniques for performing caesarean section. Best Pract Res Clin Obstet Gynaecol. 2001;15:17–47.Google Scholar

Pinder, AJ, Dresner, M, Calow, C, et al.. Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. Int J Obstet Anesth. 2002;11:156–9.Google Scholar

Badalian, SS, Silverman, RK, Aubry, RH, et al. Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report. J Reprod Med. 2000;45:149–52.Google Scholar

Wong, PS, Constantinides, S, Kanellopoulos, V, et al. Primary pulmonary hypertension in pregnancy. J R Soc Med. 2001;94:523–5.Google Scholar

Ghai, B, Mohan, V, Khetarpal, M, et al. Epidural anesthesia for cesarean section in a patient with Eisenmenger’s syndrome. Int J Obstet Anesth. 2002;11:44–7.Google Scholar

O’Hare, R, McLoughlin, C, Milligan, K, et al. Anaesthesia for caesarean section in the presence of severe primary pulmonary hypertension. Br J Anaesth. 1998;81:790–2.Google Scholar

Weeks, SK, Smith, JB. Obstetric anaesthesia in patients with primary pulmonary hypertension. Can J Anaesth. 1991;38:814–16.Google Scholar

Blaise, G, Langleben, D, Hubert, B. Pulmonary arterial hypertension: Pathophysiology and anesthetic approach. Anesthesiology. 2003;99:1415–32.Google Scholar

Elliott, P, Andersson, B, Arbustini, E et al. Classification of the cardiomyopathies: A position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J 2008;29:270–6.Google Scholar

Van Tintelen, JP, Pieper, PG, Van Spaendonck-Zwarts, KY, et al. Pregnancy, cardiomyopathies and genetics. Cardiovasc Res 2014;101:571–8.Google Scholar

Anderson, JL, Horne, BD. Birthing the genetics of peripartum cardiomyopathy. Circulation 2010;121:2157–9.Google Scholar

Rapezzi, C, Arbustini, E, Caforio, A et al. Diagnostic work up in cardiomyopathies: Bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:1448–58.Google Scholar

Blauwet, L, Sliwa, K. Peripartum cardiomyopathy. Obstet Med 2011;4:44–52.Google Scholar

Grewal, J, Siu, SC, Ross, HJ, et al. Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol 2010;55:45–52.Google Scholar

Blatt, A, Svirski, R, Morawsky, G, et al. Short and long-term outcome of pregnant women with pre-existing dilated cardiomyopathy: An NTproBNP and echocardiography-guided study. IMAJ 2010;12:613–16.Google Scholar

Palojoki, E, Kaartinen, M, Kaaja, R, et al. Pregnancy and childbirth in carriers of the lamin A/C gene mutation. European Journal of Heart Failure 2010;12:630–3.Google Scholar

European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.Google Scholar

Sliwa, K, Hilfiker-Kleiner, D, Petrie, MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: A position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767–78.Google Scholar

Pearson, GD, Veille, JC, Rahimtoola, S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183–8.Google Scholar

Hibbard, JU, Lindheimer, M, Lang, RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Am J Obstet Gynecol 1999;94:311–16.Google Scholar

Elkayam, U, Akhter, MW, Singh, H, et al. Pregnancy-associated cardiomyopathy: Clinical characteristics and a comparison between early and late presentation. Circulation 2005;111:2050–5.Google Scholar

Bachelier-Walenta, K, Hilfiker-Kleiner, D, Sliwa, K. Acute heart failure: Is it peripartum cardiomyopathy or not? Obstet Med 2013;6:42–4.Google Scholar

Fett, JD, Christie, LG, Carraway, RD, et al. Unrecognized peripartum cardiomyopathy in Haitian women. Int J Gynaecol Obstet. 2005;90(2):161–6.Google Scholar

Lim, CP, Sim, DK. Peripartum cardiomyopathy: Experience in an Asian tertiary centre. Singapore Med J. 2013;54(1):24–7.Google Scholar

Kolte, D, Khera, S, Aronow, WS, et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: A nationwide population-based study. J Am Heart Assoc. 2014;4;3(3):e001056.Google Scholar

Hilfiker-Kleiner, D, Sliwa, K. Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol. 2014;11(6):364–70.Google Scholar

Sliwa, K, Hilfiker-Kleiner, D, Mebazaa, A, et al. EURObservational Research Programme: A worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Eur J Heart Fail. 2014;16(5):583–91.Google Scholar

Kao, DP, Hsich, E, Lindenfeld, J. Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. JACC Heart Fail. 2013;1(5):409–16.Google Scholar

Shani, H, Kuperstein, R, Berlin, A, et al. Peripartum cardiomyopathy—risk factors, characteristics and long-term follow-up. J Perinat Med. 2015;43(1):95–101.Google Scholar

Prasad, GS, Bhupali, A, Prasad, S, Patil, AN, Deka, Y. Peripartum cardiomyopathy—case series. Indian Heart J. 2014 Mar-Apr;66(2):223–6.Google Scholar

Morales, A, Painter, T, Li, R, et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010;121:2176–82.Google Scholar

Van Spaendonck-Zwarts, KY, van Tintelen, JP, van Veldhuisen, DJ, et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 2010;121:2169–75.Google Scholar

Van Spaendonck-Zwarts, KY, Posafalvi, A, van den Berg, MP, et al. Titn gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J. 2014;35(32):2165–73.Google Scholar

Midei, MG, DeMent, SH, Feldman, AM, Hutchins, GM, Baughman, KL. Peripartum myocarditis and cardiomyopathy. Circulation 1990;81:922–8.Google Scholar

Felker, GM, Thompson, RE, Hare, JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077–84.Google Scholar

Bultmann, BD, Klingel, K, Nabauer, M, Wallwiener, D, Kandolf, R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 2005;193:363–5.Google Scholar

Sliwa, K, Forster, O, Libhaber, E, et al. Peripartum cardiomyopathy: Inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006;27:441–6.Google Scholar

Huang, GY, Zhang, LY, Long-Le, MA, Wang, LX. Clinical characteristics and risk factors for peripartum cardiomyopathy. Afr Health Sci. 2012 Mar;12(1):26–31.Google Scholar

Warraich, RS, Sliwa, K, Damasceno, A, et al. Impact of pregnancy-related heart failure on humoral immunity: Clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. Am Heart J 2005;150:263–9.Google Scholar

Hilfiker-Kleiner, D, Sliwa, K. Pathophysiology and epidemiology of peripartum cardiomyopathy.Nat Rev Cardiol 2014 Jun;11(6):364–70.Google Scholar

Hilfiker-Kleiner, D, Kaminski, K, Podewski, E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007;128(3):589–600.Google Scholar

Sliwa, K, Blauwet, L, Tibazarwa, K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: A proof-of-concept pilot study. Circulation. 2010 Apr 6;121(13):1465–73.Google Scholar

Elkayam, U. Clinical characteristics of peripartum cardiomyopathy in the United States: Diagnosis, prognosis, and management. J Am Coll Cardiol. 2011 Aug 9;58(7):659–70.Google Scholar

Royal College of Obstetricians and Gynaecologists. RCOG Green Top Guideline. No. 37a. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. 2015. [https://www.rcog.org.uk/globalassets/documents/guidelines/gtg-37a.pdf] Accessed August 7, 2015.Google Scholar

Mohan, A, Nelson-Piercy, C. Drugs and therapeutics, including contraception, for women with heart disease. In: Walker, F, O’Brien, P, eds. Heart Disease in Pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology. 2014;28(4):471–82.Google Scholar

Safirstein, JG1, Ro, AS, Grandhi, S, et al. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol. 2012;154(1):27–31.Google Scholar

Witlin, AG, Mabie, WC, Sibai, BM. Peripartum cardiomyopathy: A longitudinal echocardiographic study. Am J Obstet Gynecol 1997;177:1129–32.Google Scholar

National Institute for Health and Care Excellence. NICE Guideline GC108. Chronic heart failure: Management of chronic heart failure in adults in primary and secondary care. 2010. [http://www.nice.org.uk/guidance/cg108] Accessed August 10, 2015.Google Scholar

Mouquet, F, Mostefa Kara, M, Lamblin, N, et al. Unexpected and rapid recovery of left ventricular function in patients with peripartum cardiomyopathy: Impact of cardiac resynchronization therapy. Eur J Heart Fail 2012;14(5):526–9.Google Scholar

National Institute for Health and Care Excellence. NICE Technology Appraisal TA 314. Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (review of TA95 and TA120). 2014. [https://www.nice.org.uk/guidance/ta314] Accessed August 10, 2015.Google Scholar

Cantwell, R, Clutton-Brock, T, Cooper, G. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the UK. BJOG, 118 (Suppl 1):1–203.Google Scholar

Murali, S, Baldisseri, MR. Peripartum cardiomyopathy. Crit Care Med 2005;33(10 Suppl):S340–6.Google Scholar

Blauwet, LA, Libhaber, E, Forster, O, et al. Predictors of outcome in 176 South African patients with peripartum cardiomyopathy. Heart. 2013 Mar;99(5):308–13.Google Scholar

Pillarisetti, J, Kondur, A, Alani, A, et al. Peripartum cardiomyopathy: Predictors of recovery and current state of implantable cardioverter-defibrillator use. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2831–9.Google Scholar

Cooper, LT, Mather, PJ, Alexis, JD, et al. Myocardial recovery in peripartum cardiomyopathy: Prospective comparison with recent onset cardiomyopathy in men and non-peripartum women. J Card Fail. 2012;18:28–33.Google Scholar

Lampert, MB, Weinert, L, Hibbard, J, et al. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Obstet Gynecol 1997;176:189–95.Google Scholar

Elkayam, U. Pregnant again after peripartum cardiomyopathy: To be or not to be? Eur Heart J 2002;23:753–6.Google Scholar

Witlin, AG, Mabie, WC, Sibai, BH. Peripartum cardiomyopathy: An ominous diagnosis. Am J Obstet Gynecol 1997;176:182–8.Google Scholar

Dorbala, S, Brozena, S, Zeb, S, et al. Risk stratification of women with peripartum cardiomyopathy at initial presentation: A dobutamine stress echocardiography study. J Am Soc Echocardiogr 2005;18:45–8.Google Scholar

Goland, S, Bitar, F, Modi, K et al. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Cardiac Fail. 2011;17:426–30.Google Scholar

Bernstein, PS, Magriples, U. Cardiomyopathy in pregnancy: A retrospective study. Am J Perinatol 2001;18:163–8.Google Scholar

Katsuragi, S, Omoto, A, Kamiya, C, et al. Risk factors for maternal outcome in pregnancy complicated with dilated cardiomyopathy. J Perinatol 2012;32:170–5.Google Scholar

Suri, V, Aggarwal, N, Kalpdev, A, et al. Pregnancy with dilated and peripartum cardiomyopathy: Maternal and fetal outcome. Arch Gynecol Obstet 2013;287:195–9.Google Scholar

Saltzberg, MT, Szymkiewicz, S, Bianco, NR. Characteristics and outcomes of peripartum vs non peripartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail 2012;18:21–7.Google Scholar

Demakis, JG, Rahimtoola, SH, Sutton, GC, et al. Natural course of peripartum cardiomyopathy. Circulation 1971;44:1053–61.Google Scholar

Elkayam, U, Tummala, PP, Rao, K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344 :1567–71.Google Scholar

Fett, JD, Fristoe, KL, Welsh, SN. Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers. Int J Gynaecol Obstet 2010;109:34–6.Google Scholar

Avila, WS, de Carvalho, ME, Tschaen, CK, et al. Pregnancy and peripartum cardiomyopathy. A comparative and prospective study. Arq Bras Cardiol 2002;79:484–93.Google Scholar

Mishra, TK, Swain, S, Routray, SN. Peripartum cardiomyopathy. Int J Gynecol Obstet 2006;95:104–9.Google Scholar

Habli, M, O’Brien, T, Nowack, E, et al. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol 2008;199:415,e1–5.Google Scholar

Modi, KA, Illum, S, Jariatul, K, Caldito, G, Reddy, PC. Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. Am J Obstet Gynecol 2009;201: 171.e1–5.Google Scholar

Elliott, P, McKenna, WJ. Hypertrophic cardiomyopathy. Lancet 2004;363:1881–91.Google Scholar

Schinkel, AF. Pregnancy in women with hypertrophic cardiomyopathy. Cardiol Rev 2014;22:217–22.Google Scholar

Thaman, R, Varnava, A, Hamid, MS, et al. Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart 2003;89:752–6.Google Scholar

Autore, C, Conte, MR, Piccininno, M, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:1864–9.Google Scholar

Probst, V, Langlard, JM, Desnos, M, et al. Familial hypertrophic cardiomyopathy. French study of the duration and outcome of pregnancy. Arch Mal Coeur Vaiss 2002;95:81–6.Google Scholar

Tanaka, H, Kamiya, C, Katsuragi, S, et al. Cardiovascular events in pregnancy with hypertrophic cardiomyopathy. Circ J. 2014;78:2501–6.Google Scholar

Mogensen, J, Arbustini, E. Restrictive cardiomyopathy. Curr Opin Cardiol. 2009;24:214–20.Google Scholar

Smith, W, Members of CSANZ Cardiovascular Genetics Working Group. Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy. Heart Lung Circ. 2011;20:757–60.Google Scholar

Bauce, B, Daliento, L, Frigo, G, et al. Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur J Obstet Gynecol Reprod Biol. 2006;127:186–9.Google Scholar

Iriyama, T, Kamei, Y, Kozuma, S, et al. Management of patient with arrhythmogenic right ventricular cardiomyopathy during pregnancy. J Obstet Gynaecol Res 2013;39:390–4.Google Scholar

Lee, LC, Bathgate, SL, Macri, CJ. Arrhythmogenic right ventricular dysplasia in pregnancy: A case report. J Reprod Med 2006;51:725–8.Google Scholar

Murray, B, Tichnell, C, James, C, Tandri, H, Calkins, H. Pregnancy in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2013;62:1910–11.Google Scholar

Cozzolino, M, Perelli, F, Corioni, S, Carpinella, G, Mecacci, F. Successful obstetric management of arrhythmogenic right ventricular cardiomyopathy. Gynecol Obstet Invest 2014;78:266–71.Google Scholar

Doyle, NM, Monga, M, Montgomery, B, et al. Arrhythmogenic right ventricular cardiomyopathy with implantable cardioverter defibrillator placement in pregnancy. J Matern Fetal Neonatal Med 2005;18:141–4.Google Scholar

Stec, S, Krynski, T, Baran, J, Kulakowski, P. “Rescue” ablation of electrical storm in arrhythmogenic right ventricular cardiomyopathy in pregnancy. BMC Cardiovasc Disord 2013;13:58.Google Scholar

Croft, P, Hannaford, PC. Risk factors for acute myocardial infarction in women: Evidence from the Royal College of General Practitioners’ oral contraception study. BMJ. 1989;298(6667):165–8.Google Scholar

James, AH, Jamison, MG, Biswas, MS, et al. Acute myocardial infarction in pregnancy: A United States population-based study. Circulation. 2006;113(12):1564–71.Google Scholar

Roth, A, Elkayam, U. Acute myocardial infarction associated with pregnancy. Ann Intern Med. 1996;125(9):751–62.Google Scholar

Elkayam, U, Jalnapurkar, S, Barakkat, MN, et al. Pregnancy-associated acute myocardial infarction: A review of contemporary experience in 150 cases between 2006 and 2011. Circulation. 2014;129(16):1695–702.Google Scholar

Hunter, S, Robson, SC. Adaptation of the maternal heart in pregnancy. Br Heart J. 1992;68(6):540–3.Google Scholar

Roth, A, Elkayam, U. Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol. 2008;52(3):171–80.CrossRefGoogle ScholarPubMed

Ascarelli, MH, Grider, AR, Hsu, HW. Acute myocardial infarction during pregnancy managed with immediate percutaneous transluminal coronary angioplasty. Obstet Gynecol. 1996;88(4 Pt 2):655–7.Google Scholar

Badui, E, Enciso, R. Acute myocardial infarction during pregnancy and puerperium: A review. Angiology. 1996;47(8):739–56.Google Scholar

Lewis, G. (Ed). Saving Mothers’ Lives. Reviewing maternal deaths to make motherhood safer: 2006–2008. The eighth Report of the Confidential Enquiry into Maternal Deaths BJOG. 2011 118 (11):1402–3; discussion 3–4.Google Scholar

Ray, P, Murphy, GJ, Shutt, LE. Recognition and management of maternal cardiac disease in pregnancy. Br J Anaesth. 2004;93(3):428–39.Google Scholar

European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.Google Scholar

Teunen, D. The European Directive on health protection of individuals against the dangers of ionising radiation in relation to medical exposures (97/43/EURATOM). J Radiol Prot. 1998;18(2):133–7.Google Scholar

Colletti, PM, Lee, KH, Elkayam, U. Cardiovascular imaging of the pregnant patient. AJR Am J Roentgenol. 2013;200(3):515–21.Google Scholar

Bates, SM, Greer, IA, Middeldorp, S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e691S-736S.Google Scholar

U.S. Food and Drug Administration. Plavix Prescribing Information. www.accessdata.fda.gov/drugsatfda_docs/label/2013/020839s058lbl.pdf. Accessed September 9, 2014.[updated December 2013]Google Scholar

Heinonen, OP, Sloan, D, Shapiro, S. Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group; 1977.Google Scholar

Sheikh, AU, Harper, MA. Myocardial infarction during pregnancy: Management and outcome of two pregnancies. Am J Obstet Gynecol. 1993;169(2 Pt 1):279–83; discussion 83–4.Google Scholar

Shalev, Y, Ben-Hur, H, Hagay, Z, et al. Successful delivery following myocardial ischemia during the second trimester of pregnancy. Clin Cardiol. 1993;16(10):754–6.Google Scholar

Briggs, GG, Freeman, RK, Yaffe, SJ, eds. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Baltimore: Williams and Wilkins; 1994.Google Scholar

Stuart, MJ, Gross, SJ, Elrad, H, et al. Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis. N Engl J Med. 1982;307(15):909–12.Google Scholar

Zierler, S, Rothman, KJ. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med. 1985;313(6):347–52.Google Scholar

Viinikka, L, Hartikainen-Sorri, AL, Lumme, R, et al. Low dose aspirin in hypertensive pregnant women: Effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. Br J Obstet Gynaecol. 1993;100(9):809–15.Google Scholar

CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet. 1994;343(8898):619–29.Google Scholar

Buttar, HS. An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem. 1997;176(1–2):61–71.Google Scholar

Hanssens, M, Keirse, MJ, Vankelecom, F, et al. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol. 1991;78(1):128–35.Google Scholar

Opasich, C, Russo, A, Colombo, E, et al. Your cardiac patient wants to become a mother. Risk considerations and advice. Part II–Your cardiac patient is pregnant. Ital Heart J. 2000;1(10):667–73.Google Scholar

Elkayam, U. Pregnancy and Cardiovascular Disease. In: Braunwald, E, ed. Heart Disease: A Textbook of Cardiovascular Medicine, 5th edn. Philadelphia: W.B. Saunders; 1997. pp. 1843–64.Google Scholar

U.S. Food and Drug Administration. Spironolactone Prescribing Information. www.accessdata.fda.gov/drugsatfda_docs/label/2008/012151s062lbl.pdf. Accessed September 9, 2014.[updated November 2008].Google Scholar

U.S. Food and Drug Administration. Simvastatin Prescribing Information. www.accessdata.fda.gov/drugsatfda_docs/label/2010/019766s078lbl.pdf. Accessed September 9, 2014.[updated March 2010].Google Scholar

Patel, A, Asopa, S, Tang, AT, et al. Cardiac surgery during pregnancy. Tex Heart Inst J. 2008;35(3):307–12.Google Scholar

Elassy, SM, Elmidany, AA, Elbawab, HY. Urgent cardiac surgery during pregnancy: A continuous challenge. Ann Thorac Surg. 2014;97(5):1624–9.Google Scholar

Roos-Hesselink, JW, Ruys, TP, Stein, JI, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: Results of a registry of the European Society of Cardiology. Eur Heart J. 2013;34(9):657–65.Google Scholar

Gowda, RM, Khan, IA, Mehta, NJ, et al. Cardiac arrhythmias in pregnancy: Clinical and therapeutic considerations. Int J Cardiol. 2003;88(2–3):129–33.Google Scholar

Niwa, K, Warita, N, Sunami, Y, et al. Prevalence of arrhythmias and conduction disturbances in large population-based samples of children. Cardiol Young 2004;14:68–74.Google Scholar

Shotan, A, Ostrzega, E, Mehra, A, et al. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol 1997;79:1061–4.Google Scholar

Li, JM, Nguyen, C, Jogler, JA, et al. Frequency and outcome of arrhythmias complicating admission during pregnancy: Experience from a high volume and ethnically-diverse obstetric service. Clin Cardiol 2008;31:538–41.Google Scholar

Roos-Hesselink, JW, Ruys, TP, Stein, JI, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: Results of a registry of the European Society of Cardiology. Eur Heart J 2013;34:657–65.Google Scholar

Tateno, S, Niwa, K, Nakazawa, M, et al. Arrhythmia and conduction disturbances in patients with congenital heart disease during pregnancy–Multicenter study. Circ J 2003;67:992–7.Google Scholar

Nakagawa, M, Katou, S, Ichinose, M, et al. Characteristics of new-onset ventricular arrhythmias in pregnancy. J Electrocardiol 2004;37:47–53.Google Scholar

Widerhorn, J, Widerhorn, AL, Rahimtoola, SH, et al. WPW syndrome during pregnancy: Increased incidence of supraventricular arrhythmias. Am Heart J 1992;123:796–8.Google Scholar

Page, RL, Hamdan, MH, Joglar, JA. Arrhythmias occurring during pregnancy. Cardiac Electrophysiol Rev 2002;6:136–9.Google Scholar

Seth, R, Moss, AJ, McNitt, S, et al. Long QT syndrome and pregnancy. J Am Coll Cardiol 2007;49:1092–8.Google Scholar

Hidaka, N, Chiba, Y, Fukushima, K, et al. Pregnant women with complete atrioventricular block: Perinatal risks and review of management. Pacing Clin Electrophysiol 2011;34:1161–76.Google Scholar

JCS Joint Working Group. Guidelines for Indication and Management of Pregnancy and Delivery in Women with Heart Disease (JCS 2010): Digest version. Circ J 2012;76:240–60.Google Scholar

Ferrero, S, Colombo, BM, Ragni, N. Maternal arrhythmias during pregnancy. Arch Gynecol Obstet 2004;269:244–53.Google Scholar

Romem, A, Romem, Y, Katz, M, et al. Incidence and characteristics of maternal cardiac arrhythmias during labor. Am J Cardiol 2004;93:931–3.Google Scholar

Siu, SC, Sermer, M, Harrison, DA, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997;96:2789–94.Google Scholar

Whittemore, R, Hobbins, JC, Engle, MA. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. Am J Cardiol 1982;50:641–51.Google Scholar

Brodsky, M, Doria, R, Allen, B, et al. New-onset ventricular tachycardia during pregnancy. Am Heart J 1992;123:933–41.Google Scholar

Joglar, JA, Page, RL. Antiarrhythmic drugs in pregnancy. Curr Opin Cardiol 2001;16:40–5.Google Scholar

Siu, SC, Sermer, M, Colman, JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515–21.Google Scholar

Zuber, M, Gautschi, N, Oechslin, E, et al. Outcome of pregnancy in women with congenital shunt lesions. Heart 1999;81:271–5.Google Scholar

Drenthen, W, Pieper, PG, Roos-Hesselink, JW, et al. Outcome of pregnancy in women with congenital heart disease: A literature review. J Am Coll Cardiol 2007;49:2303–11.Google Scholar

Khairy, P, Ouyang, DW, Fernandes, SM, et al. Pregnancy outcomes in women with congenital heart disease. Circulation 2006;113:5170–524.Google Scholar

Cox, JL, Gardner, MJ. Treatment of cardiac arrhythmias during pregnancy. Prog Cardiovasc Dis 1993;36:137–78.Google Scholar

Briggs, GG, Freeman, RK, Yaffe, SJ. Drugs in Pregnancy and Lactation, 7th edn. Philadelphia: Lippincott Williams and Willkins, 2005.Google Scholar

Lipman, S, Cohen, S, Einav, S, et al. The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Management of Cardiac Arrest in Pregnancy. Anesth Analg 2014;118:1003–16.Google Scholar

Elkayam, U, Goodwin, TM, Jr. Adenosine therapy for supraventricular tachycardia during pregnancy. Am J Cardiol 1995;75:521–3.Google Scholar

Byerly, WG1, Hartmann, A, Foster, DE, Tannenbaum, AK. Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia. Ann Emerg Med 1991;20(5):552-4.Google Scholar

Wagner, X, Jouglard, J, Moulin, M, et al. Coadministration of flecainide acetate and sotalol during pregnancy: Lack of teratogenic effects, passage across the placenta, and excretion in human breast milk. Am Heart J 1990;119:700–2.Google Scholar

Gowda, RM, Khan, IA, Mehta, NJ, et al. Cardiac arrhythmias in pregnancy: Clinical and therapeutic considerations. Int J Cardiol 2003;88:129–33.Google Scholar

Task force on the management of cardiovascular disease during pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular disease during pregnancy. Euro Heart J 2003;24:761–81.Google Scholar

Miyoshi, T, Kamiya, C, Katsuragi, S, et al. Safety and efficacy of implantable cardioverter-defibrillator during pregnancy and after delivery. Circ J 2013;77:1166–70.Google Scholar

Berruezo, A, Díez, GR, Berne, P, et al. Low exposure radiation with conventional guided radiofrequency catheter ablation in pregnant women. Pacing Clin Electrophysiol 2007;30:1299–302.Google Scholar

Thaman, R1. Curtis, S, Faganello, G, et al. Cardiac outcome of pregnancy in women with a pacemaker and women with untreated atrioventricular conduction block. Europace 2011;13:859–63.Google Scholar

Baumgartner, H. Reproductive issues in adults with congenital heart disease: Arrhythmias during pregnancy: Importance, diagnosis and therapy. Thorac Cardiov Surg 2001;49:94–7.Google Scholar

Chow, TH, Galvin, J, McGovern, B. Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol 1998;82:581–621.Google Scholar

Meidahl Petersen, K, Jimenez-Solem, E, Andersen, JT, et al. β-Blocker treatment during pregnancy and adverse pregnancy outcomes: A nationwide population-based cohort study. BMJ Open 2012;2(4)pii:e001185.Google Scholar

Ovadia, M, Brito, M, Hoyer, GL, et al. Human experience with amiodarone in the embryonic period. Am J Cardiol 1994;73:316–17.Google Scholar

Veldtman, GR, Connolly, HM, Grogan, M, et al. Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol 2004;44:174–80.Google Scholar

Kamiya, CA, Iwamiya, T, Neki, R, et al. Outcome of pregnancy and effects on the right heart in women with repaired tetralogy of Fallot. Circ J 2012;76:957–63.Google Scholar

Connolly, HM, Warnes, CA. Ebstein’s anomaly: outcome of pregnancy. J Am Coll Cardiol 1994;23:1194–8.Google Scholar

Katsuragi, S, Kamiya, C,Yamanaka, K, et al. Risk factors for maternal and fetal outcome in pregnancy complicated by Ebstein anomaly. Am J Obstet Gynecol 2013;209:452.e1–6.Google Scholar

Connolly, HM, Grogan, M, Warnes, CA. Pregnancy among women with congenitally corrected transposition of great arteries. J Am Coll Cardiol 1999;6:1692–5.Google Scholar

Drenthen, W, Pieper, PG, Ploeg, M, et al. Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries, Euro Heart J 2005;26:2588–95.Google Scholar